Cryoablation of Kidney Tumour Appears Successful With Few Complications: Presented at SIR
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Cryoablation of Kidney Tumour Appears Successful With Few Complications: Presented at SIR

By Ed Susman

WASHINGTON, DC -- March 25, 2008 -- Treatment of kidney tumours by cryoablation successfully destroys the lesions without causing major complications for the patients, researchers reported here at the Society of Interventional Radiology [SIR] 33rd Annual Scientific Meeting.

Percutaneous cryoablation using computed tomography (CT) guidance is a viable treatment option for selected small renal cell tumours and offers good short-term results and no major complications, said investigator Mark A. Gibson, MD, Resident in Diagnostic Radiology, Eastern Virginia Medical School, Norfolk, Virginia.

In the retrospective study, Dr. Gibson and colleagues identified 14 men and 13 women who underwent a total of 30 cryoablation procedures to eliminate tumours in the kidneys. The average age of the patients was 67 years.

"The cases selected for cryoablation were in predominantly high-risk surgical patients with small tumours felt [to be] amenable to percutaneous therapy," Dr. Gibson said in his featured poster presentation on March 18.

Of the 27 tumours treated, 19 were renal cell carcinoma, 5 other tumours were also malignant or were premalignant, and 3 tumours were benign lesions, Dr. Gibson said.

Patients were placed under conscious sedation or general anaesthesia while doctors guided catheters to the long axis of the tumour using 1 to 4 probes for each patient so that the ice ball would grow medially into the tumour.

The tumours were frozen at a temperature of -100 Celsius to -120 Celsius for 10 minutes; thawing was permitted for 8 minutes and then the tumours were frozen again for another 10 minutes. When deemed necessary, doctors injected percutaneously dextrose 5% or saline solution to create a buffer between vital structures, such as the bowel.

Three tumours recurred and were subsequently successfully retreated with cryoablation, said Dr. Gibson. Mean time to recurrence in these 3 cases was 10 months. He said that technical success in freezing the tumours was 100%.

All patients underwent CT scans or magnetic resonance imaging that documented a renal mass. Percutaneous biopsies were performed prior to cryotherapy.

[Presentation title: CT Guided Percutaneous Cryoablation of Renal Tumours. Abstract 329]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities